IL13 and COVID-19: By facilitating more precise epitope identification,DeepEpilL13 offers a potential avenue to accelerate the explorationand development of novel therapeutic interventions for IL-13-mediateddisorders, including allergic diseases, inflammatory conditions, andviral infections such as COVID-19, with the prospect of positivelyimpacting public health.